Roquette acquires Crest Cellulose, expanding global reach of plant-based excipients portfolio
Roquette has completed its acquisition of India-based excipient manufacturer Crest Cellulose to continue realizing its strong growth ambitions and meet rising global demand for high-quality plant-based excipients.
Workers in lab. Image courtesy of Roquette.
Roquette (La Madeleine, France) has completed its acquisition of India-based excipient manufacturer Crest Cellulose to continue realizing its strong growth ambitions and meet rising global demand for high-quality plant-based excipients. All excipients produced at the facility—Microcel microcrystalline cellulose, Lycatab CT partially pregelatinized starch, and Roquette magnesium stearate—adhere to Roquette’s rigorous quality standards and all major international regulatory requirements.
“At Roquette, we believe true innovation can only be achieved in an environment where ingredient safety is completely assured,” said Paul Smaltz, vice president of Roquette Pharma Solutions, in a press release. “There’s no room for compromise or short cuts when tackling the world’s greatest health challenges. The team at Crest Cellulose share our conviction that quality is king, always striving to optimize processes and redefine what’s possible in drug delivery. As a global leader in health and nutrition, we’re excited to harness our newly expanded capabilities to support our network of customers and partners in India, Asia and the rest of the world.”
Crest Cellulose recently become the latest recipient of the Greentech “Environmental Protection” award, which gives Roquette an opportunity to expand its reach of sustainable development initiatives, Smaltz said. “For Crest Cellulose and its customers, this means sustainable development will become central to every operation, ensuring we deliver top quality solutions that champion people, the planet and prosperity,” he said. “Supporting our commitment to reducing greenhouse gas emissions* by 25% between 2021 and 2030, plans are in motion to install an additional 0.5-megawatt solar panel to the 10 kilowatts already in place at the site. This investment is designed to provide renewable energy for decades to come.”
(*) direct emissions produced by the company (scope 1) and indirect emissions related to the energy purchased and consumed by the company (scope 2).
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
